Older Adults Using Cannabis for Sleep Differ in Patterns From Other Cannabis Users, Small Clinic Survey Finds

A descriptive cross-sectional survey of cannabis-using older adults at a single academic geriatrics clinic identifies higher frequency use and greater preference for THC-containing products among those reporting sleep-related cannabis use, but the very small subgroup size and demographic homogeneity of the sample substantially limit the reliability and generalizability of these preliminary findings.

Why This Matters

Sleep disturbance affects 40 to 70 percent of older adults and is associated with falls, cognitive decline, and diminished quality of life. Cannabis use in this population is rising rapidly, yet clinicians have almost no empirical data describing how older adults actually consume cannabis for sleep or what products they prefer. Without descriptive baselines, it is impossible to design the efficacy and safety studies this population urgently needs. This survey, though limited, represents one of the first attempts to characterize sleep-specific cannabis use patterns in a geriatric clinical setting.

Clinical Summary

Cannabis use among adults aged 65 and older has increased substantially over the past decade, yet empirical data on use patterns remain sparse, particularly for specific indications such as sleep disturbance. This anonymous cross-sectional survey, conducted by Winiger and colleagues at the University of California San Diego geriatrics clinic in 2019 and published in BMC Geriatrics, distributed questionnaires to 601 clinic attendees over approximately ten weeks. Of 568 completed surveys, 82 respondents reported current or recent cannabis use. The study compared the 24 individuals (29 percent of users) who identified sleep disturbance as a reason for cannabis use against the remaining 58 cannabis users reporting other indications. The rationale for this comparison rests on the observation that cannabinoid receptors participate in sleep-wake regulation, and THC in particular has been reported to reduce sleep onset latency in some laboratory studies, though evidence remains inconsistent.

Sleep-disturbance users consumed cannabis daily or weekly at significantly higher rates than other users (76 percent versus 43 percent, p=.01) and were more likely to use THC-containing products rather than CBD-only formulations (62 percent versus 32 percent, p less than .01). These individuals also targeted a greater number of symptoms or conditions simultaneously (mean 3.17 versus 1.12, p less than .01), with 22 of 24 also using cannabis for at least one additional indication. A trend toward higher female representation was observed (75 percent versus 53 percent, p=.07) but did not meet conventional significance thresholds. Critical limitations include the extremely small sleep subgroup, a predominantly non-Hispanic White and highly educated sample from a single academic clinic, reliance on self-reported and unvalidated survey items, absence of any objective sleep measures, and the use of a liberal p less than .10 significance threshold. The authors explicitly note that these findings are hypothesis-generating and that prospective, adequately powered studies with validated sleep outcomes are needed before any clinical recommendations can follow.

Dr. Caplan’s Take

I see this question regularly: an older patient who is already using cannabis mentions they started it for sleep, or asks whether they should. What this study captures, honestly, is something we already suspect from clinical experience. Older adults using cannabis for sleep tend to use it frequently and tend to gravitate toward THC-dominant products. But with only 24 people in the sleep subgroup, all from one clinic with a very specific demographic profile, these data do not move us meaningfully closer to knowing whether cannabis is actually helping their sleep or whether the pattern simply reflects heavier users attributing benefit to a product they were already consuming for other reasons.

In practice, I treat this as a conversation starter, not an evidence base. When an older patient tells me they are using cannabis for sleep, I ask about the product, the dose, the frequency, and whether they have noticed next-day sedation, balance changes, or cognitive effects. I do not recommend cannabis initiation for sleep in this population given the absence of controlled efficacy data and the known risks of THC in older adults, including falls and confusion. I focus instead on evidence-supported sleep hygiene strategies and established pharmacological options when warranted, while keeping the door open for better data to emerge.

Clinical Perspective

This study sits at the very earliest stage of the research arc: descriptive characterization of a behavior pattern. It confirms that a meaningful fraction of older cannabis users report sleep as a use indication and provides preliminary signals about product type and frequency preferences. It does not confirm, challenge, or resolve any question about cannabis efficacy for sleep, nor does it establish safety in this population. Clinicians should recognize that the near-universal comorbid use of cannabis for other conditions among the sleep subgroup (22 of 24 individuals) makes it difficult to isolate sleep-directed use as a distinct behavior rather than a feature of generally heavier medicinal cannabis consumption. No outcome data of any kind were collected, so the study cannot support patient-facing claims about benefit.

From a safety standpoint, the preference for THC-containing products in this subgroup is worth noting. THC carries known risks in older adults, including impaired balance, increased fall risk, cognitive disruption, and potential interactions with commonly prescribed medications such as anticoagulants, benzodiazepines, and anticholinergics. Clinicians should proactively screen older patients for cannabis use during medication reconciliation, particularly those reporting sleep complaints, and should document the type of product, cannabinoid composition, and frequency of use. This pragmatic screening step is supported by available evidence even when the therapeutic question itself remains unresolved.

Study at a Glance

Study Type

Cross-sectional anonymous survey (descriptive)

Population

Older adults attending a single academic geriatrics clinic; 82 cannabis users, 24 reporting sleep-related use

Intervention

None (observational survey of existing cannabis use patterns)

Comparator

Cannabis users reporting indications other than sleep disturbance (N=58)

Primary Outcomes

Self-reported cannabis use frequency, product type (THC vs. CBD), number of targeted conditions

Sample Size

568 survey respondents; 82 cannabis users analyzed; 24 in sleep subgroup

Journal

BMC Geriatrics

Year

2019

DOI or PMID

PMID: 31856738

Funding Source

Not explicitly reported in available data

What Kind of Evidence Is This

This is a single-site, cross-sectional, anonymous patient survey generating purely descriptive and associational data. It sits near the base of the evidence hierarchy, below case-control studies and far below controlled trials or systematic reviews. The most important inference constraint is that cross-sectional design precludes any determination of temporal sequence or causality. The study cannot establish whether cannabis use improves sleep, whether sleep problems drive cannabis use, or whether both are explained by unmeasured confounders.

How This Fits With the Broader Literature

Very little published research specifically characterizes cannabis use patterns for sleep among older adults, making this study one of a small handful of empirical data points. Prior population-level surveys such as those from the National Survey on Drug Use and Health have documented rising cannabis use in adults over 65, and a 2020 survey by Haug and colleagues at the same institution similarly described general cannabis use patterns in geriatric clinic patients. The finding that sleep users prefer THC-containing products aligns with limited preclinical and early clinical literature suggesting THC, rather than CBD, has more pronounced acute sedative effects, though this literature is itself inconsistent and largely derived from younger populations.

Importantly, no randomized controlled trial has demonstrated cannabis efficacy for sleep disturbance in older adults. The present study does not fill that gap but does provide a descriptive foundation that could inform the design of such trials, particularly regarding dosing frequency and product composition as variables of interest.

Common Misreadings

The most likely overinterpretation is reading this study as evidence that cannabis, and THC products in particular, is effective for sleep in older adults. The study collected no sleep outcome data whatsoever. It describes what people use, not whether what they use works. The association between sleep-directed use and higher consumption frequency could equally reflect tolerance development, dependence, or simply the behavior of heavier users who attribute benefit broadly. Additionally, the p less than .10 threshold the authors employed means some reported associations, particularly the sex difference, would not be considered statistically significant by conventional standards. Treating these trends as confirmed findings overstates what the data support.

Bottom Line

This small descriptive survey documents that nearly a third of older cannabis users at one academic clinic report using cannabis for sleep, with a preference for THC products and more frequent consumption. It establishes no efficacy, no safety profile, and no causal relationships. Its value lies strictly in hypothesis generation. Clinicians should not use these findings to guide therapeutic recommendations but should recognize the prevalence of sleep-motivated cannabis use in this population and screen for it accordingly.

References

1. Winiger EA, Hitchcock LN, Bryan AD, Cinnamon Bidwell L. Cannabis use and sleep: Expectations, outcomes, and the role of age. BMC Geriatrics. 2019. PMID: 31856738.
2. Haug NA, Padula CB, Sottile JE, Vandrey R, Heinz AJ, Bonn-Miller MO. Cannabis use patterns and motives: A comparison of younger, middle-aged, and older patients. Addictive Behaviors. 2017;72:14-19.
3. Han BH, Palamar JJ. Trends in cannabis use among older adults in the United States, 2015-2018. JAMA Internal Medicine. 2020;180(4):609-611.